Is it the time to reconsider the choice of valves for cardiac surgery: mechanical or bioprosthetic? - PubMed (original) (raw)

Is it the time to reconsider the choice of valves for cardiac surgery: mechanical or bioprosthetic?

Patricia M Applegate et al. J Biomed Res. 2017.

No abstract available

Fig.1

Representative imaging of valve in valve (ViV) placement in a degenerated bioprosthetic aortic valve using Medtronic CoreValve Evolut R.

1. Khan SS, Trento A, DeRobertis M, et al. Twenty-year comparison of tissue and mechanical valve replacement[J].J Thorac Cardiovasc Surg, 2001, 122(2): 257–269. -PubMed
1. van Geldorp MW, Eric Jamieson WR, Kappetein AP, et al. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk[J].J Thorac Cardiovasc Surg, 2009, 137(4): 881–886., e1–e5. -PubMed
1. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J].J Thorac Cardiovasc Surg, 2014, 148(1): e1–e132. -PubMed
1. Anyanwu A. Surgical aortic valve replacement: biologic valves are better even in the young patient. http://www.acc.org/latest-in-cardiology/articles/2015/03/03/09/28/surgic... accessed on May 16, 2017
1. Kaneko T, Vassileva CM, Englum B, et al. Contemporary outcomes of repeat aortic valve replacement: a benchmark for transcatheter valve-in-valve procedures[J].Ann Thorac Surg, 2015, 100(4): 1298–1304. -PubMed